Quick Links
Browse By Peptide
- 5-Amino-1MQ
- Ac Sdkp Goralatide
- Ace 031
- Acetic Acid
- Acetyl Hexapeptide 3 Argireline
- Adamax
- Adipotide
- Ahk Cu
- Aicar
- Akg
- Alprostadil
- Aod 9604
- Ara 290
- Bacteriostatic Water
- Bam 15
- Bpc 157
- Bpc 157 Tb 500
- Bronchogen
- Ca Akg
- Cagrilintide
- Cardiogen
- Cartalax
- Cerebrolysin
- Chonluten
- Cjc 1295 Dac
- Cjc 1295 No Dac
- Cjc 1295 No Dac Ipamorelin
- Cortagen
- Cortagen Peptide Research Guide
- Crystagen
- Dermorphin
- Dihexa
- Dsip
- Epithalon
- Follistatin 344
- Foxo4 Dri
- Ghk Cu
- Ghrp 2
- Ghrp 6
- Glow
- Glutathione
- Gonadorelin
- Gotratix A18
- Hexarelin
- Hgh Fragment 176 191
- Humanin
- Hyaluronic Acid
- Igf 1 Des
- Igf 1 Lr3
- Ipamorelin
- Kisspeptin 10
- Klow
- Kpv
- Liraglutide
- Ll37
- Matrixyl 3000 Complex
- Mazdutide
- Melanotan I
- Melanotan Ii
- Methylene Blue
- Mgf
- Mk 677 Ibutamoren
- Mots C
- Na Epitalon Amidate
- Na Selank
- Na Semax
- Nad
- Nad Plus
- Nmn
- Nmnh
- Nonapeptide 1
- Ovagen
- Oxytocin
- Pal Ghk Peptide
- Pancragen
- Pe 22 28
- Peg Mgf
- Pentapeptide 18 Leuphasyl
- Pinealon
- Pnc 27
- Prostamax
- Pt 141
- Ptd Dbm
- Reconstitution Solution
- Resveratrol
- Retatrutide
- Retatrutide Cagrilintide
- Selank
- Semaglutide
- Semaglutide Cagrilintide
- Semax
- Sermorelin
- Servodutide
- Slu Pp 332
- Slu Pp 332 Bam15
- Snap 8
- Ss 31
- Survodutide
- Syn Ake
- Syn Coll Peptide
- Tb 500
- Tb 500 Frag
- Teriparatide
- Tesamorelin
- Tesamorelin Ipamorelin
- Tesamorelinipamorelin
- Tesofensene
- Tesofensine
- Testagen
- Thymalin
- Thymosin Alpha
- Thymosin Beta 4
- Tirzepatide
- Triptorelin
- Vesugen
- Vilon
- Vip
- Vip Peptide
Browse By Application
- Addiction
- Alzheimers
- Anti Aging
- Antimicrobial
- Anxiety
- Appetite
- Autoimmune Disorders
- Bladder Urinary Health
- Body Composition
- Bone Joint Health
- Cancer
- Cardiovascular Health
- Cellular Energy
- Circadian Health
- Cognitive Enhancement
- Cosmetic
- Crohns Disease
- Depression
- Diabetes
- Ear Hearing Health
- Endocrine Health
- Epigenetics
- Eye Health
- Fat Oxidation
- Fertility
- Glp
- Growth Hormone Optimization
- Gut Health
- Hair Scalp Health
- Hormonal Balance
- Immune System Support
- Immunomodulation
- Infection
- Inflammation
- Inflammatory Bowel Disease
- Injury Recovery
- Irritable Bowel Syndrome
- Kidney Health
- Leaky Gut
- Libido
- Liver Health
- Longevity
- Menopause
- Mens Health
- Mental Health
- Metabolic Health
- Mitochondrial Health
- Muscle Growth
- Neural Regeneration
- Neurodegenerative Diseases
- Neuroprotection
- Oncology
- Oral Dental Health
- Osteoporosis
- Pain Management
- Parkinsons
- Perimenopause
- Polycystic Ovary Syndrome
- Post Traumatic Stress Disorder
- Respiratory Health
- Sexual Health
- Skin
- Sleep
- Spinal Cord Injury
- Sports Performance
- Telomere Biology
- Thyroid
- Tissue Repair
- Weight Loss
- Womens Health
- Wound Healing
Best Supplements to Take With Retatrutide
AI Summary
Retatrutide is the first triple-hormone receptor agonist to reach late-stage clinical trials, simultaneously activating the GLP-1, GIP, and glucagon receptors in a way no other weight-loss drug currently does. The glucagon arm is what sets it apart from tirzepatide and semaglutide: it raises energy expenditure directly and drives amino acid breakdown in the liver for fuel, which means the nutritional demands on your body are genuinely higher than on any GLP-1-only drug at equivalent weight loss. The supplements that matter most are the ones that close the gaps this combination opens: protein and creatine to defend the lean mass that rapid loss would otherwise take, vitamin D and iron to catch the deficiencies that quietly kill energy and exercise tolerance, and ginger and magnesium to blunt GI side effects that are more intense on retatrutide than on its siblings. This guide explains why each one earns its slot for this compound specifically, and hands the amounts to the MyPeptidePal app, because the right dose depends on your protocol, your bloodwork, and what else you are taking.Retatrutide Asks More of Your Body Than Any Other Weight-Loss Drug
Retatrutide is not simply a more powerful version of semaglutide or tirzepatide. It is a pharmacologically different animal, and that difference has real consequences for what your body needs while you are running it.
Semaglutide works through one receptor: the GLP-1 receptor, which reduces appetite and slows the movement of food through your stomach. Tirzepatide adds a second receptor, GIP, which enhances the appetite-suppression signal and appears to reduce the nausea burden per unit of weight lost. Retatrutide does both of those things and then adds a third receptor target: the glucagon receptor. That third arm changes the calculus entirely.
Glucagon is the hormone your liver listens to when it needs to release stored energy. When the glucagon receptor is activated, your body burns more hepatic fat, raises its overall energy expenditure through thermogenesis (essentially, running hotter), and increases the rate at which it breaks down amino acids in the liver for fuel. That last point is where the protein argument on retatrutide diverges sharply from the argument on semaglutide or tirzepatide. GLP-1-only drugs reduce what you eat, which passively reduces protein intake. Retatrutide reduces what you eat AND actively burns through amino acids as an energy source in the liver. The result is a compound that puts lean mass under pressure from two directions simultaneously, not one.
The clinical trial data reflects this. Phase 2 results published in the New England Journal of Medicine showed retatrutide producing body-weight reductions of roughly 17 to 24 percent over 48 weeks depending on dose, a range that exceeds what tirzepatide achieves in comparable timeframes and substantially exceeds semaglutide. Greater total weight loss is the goal, but it also means a larger absolute volume of tissue is being lost, and without deliberate nutritional support, a meaningful portion of that tissue will be lean mass rather than fat.
The side-effect profile is proportionally more demanding than its siblings as well. Nausea affects up to 60 percent of retatrutide users at higher doses, a rate notably higher than tirzepatide's published trial data at equivalent efficacy doses. The glucagon component may contribute to GI symptoms directly, and the fact that retatrutide is pushed to doses that produce greater weight loss means users spend longer in the high-nausea titration window. Eating becomes difficult. Dietary variety collapses. Micronutrient intake falls sharply. These are not incidental side effects. They define the nutritional environment the supplement stack is built for.
Retatrutide is dosed once weekly by subcutaneous injection and has no fasted requirement. Supplements are taken daily, distributed through the week, independent of injection day. On injection day and the following 24 hours, gastric emptying slows by roughly 30 to 40 percent, which means oral supplements may absorb slightly more slowly. This is clinically minor for nutrients, but it is worth knowing if you are also managing timed oral medications.
The stack below is built for this specific pharmacological situation: a compound that suppresses intake aggressively, burns amino acids for liver fuel via glucagon signaling, produces intense GI side effects during titration, and delivers weight loss at a scale that creates its own downstream nutritional problems. No other approved or investigational weight-loss agent currently does all four at once.
Where this guide comes from
Most peptide guides are written from whatever the author could find on the internet. This one is built on something different. The MyPeptidePal Knowledge Base aggregates every published clinical study, peer-reviewed trial, in vitro finding, and documented human use case on peptides into a single continuously updated system. What makes it unique is the layer on top of the published literature: MyPeptidePal currently tracks over 10,000 active user protocols every day, with more than 900 new protocols created and refined daily by real users logging their actual results.
That means the dosing ranges, outcome timelines, and safety notes in this guide are not only sourced from published literature — they are cross-referenced against real-world protocol data from thousands of people actively using these compounds. When the research and the real-world data agree, we say so. When they diverge, we note it. The goal is the clearest, most complete picture of what the evidence actually shows.
The Supplements That Matter Most on Retatrutide
| Supplement | Role | Why it earns its slot |
|---|---|---|
| Protein (whey, casein, or plant-based) | Protects lean mass | Retatrutide suppresses intake AND burns amino acids via glucagon-activated liver metabolism, putting muscle under pressure from two directions |
| Creatine monohydrate | Protects lean mass | Maintains the energy currency muscles use during high-intensity training so strength holds through a deep caloric deficit |
| HMB | Protects lean mass | Slows the rate of muscle protein breakdown during the rapid loss phase; third line of defense on a compound producing 17 to 24 percent weight loss |
| Vitamin D3 | Corrects a deficiency | Up to 70 percent of adults are already deficient; rapid fat loss depletes adipose-stored vitamin D further over 3 to 6 months |
| Iron | Corrects a deficiency | Low ferritin collapses exercise capacity and causes the fatigue and hair shedding many users wrongly attribute to the drug itself |
| Vitamin B12 | Corrects a deficiency | Reduced dietary variety during extreme caloric restriction cuts B12 intake; supports energy metabolism and nerve function |
| Magnesium | Blunts side effects and corrects a deficiency | Addresses GI cramping and constipation from retatrutide's motility effects while also covering a shortfall common in caloric restriction |
| Ginger | Blunts a side effect | The most evidence-backed non-pharmaceutical option for nausea that affects up to 60 percent of users |
| Electrolytes | Blunts a side effect | Reduced food and fluid intake drops sodium and potassium first; depletion amplifies the nausea already present |
| Soluble fiber | Blunts a side effect | Manages constipation from slowed gastric motility; introduced once nausea has settled, not during week one of a new dose |
| Probiotics and digestive enzymes | Blunts a side effect | Supports gut bacterial populations disrupted by dramatic dietary change; reduces bloating and discomfort |
| Berberine | Amplifies the metabolic outcome | Activates a cellular energy-sensing switch that adds complementary support to the glucose and insulin improvements retatrutide produces |
There are no dose numbers on this page. The right amount of each of these depends on your actual retatrutide protocol, your current bloodwork, how far into titration you are, and what you are already eating and taking. MyPeptidePal works that out for your specific situation.
The Deficiency Problem Retatrutide Creates
Retatrutide's weight loss comes partly from dramatic caloric restriction. At higher doses, many users find themselves eating well under 1,200 calories a day without feeling hungry. That is effective for losing weight, and it is also a practical impossibility for meeting micronutrient needs through food alone. The deficiencies that follow are not theoretical. They show up in bloodwork, and they show up in how people feel and perform.
Vitamin D
Vitamin D is stored in fat tissue. As retatrutide clears that fat away, stored vitamin D is released into the bloodstream in the short term. That sounds useful, but over 3 to 6 months those stores are depleted faster than a restricted diet can replace them. The deficiency tends to arrive on a delay, which is why it often goes undetected until the second half of a protocol.
Up to 70 percent of adults are already below optimal vitamin D levels before starting any weight-loss drug. Add the adipose-depletion effect and a diet dramatically reduced in variety and volume, and low vitamin D becomes close to inevitable without supplementation on a long retatrutide course.
The consequences matter specifically for retatrutide users because low vitamin D weakens muscle function. Resistance training is the most effective tool for preserving the lean mass that the glucagon arm is actively threatening, and reduced muscle function undermines the quality of that training. Low vitamin D also contributes to fatigue and mood disruption, which impair the consistency that determines whether someone achieves a 17 percent or a 24 percent weight-loss outcome.
The marker to check is 25-hydroxyvitamin D, the form of vitamin D that circulates in the blood and reflects actual body stores. Testing at baseline and again around six months into the protocol is the standard clinical approach. Vitamin D3, taken with a fat-containing meal to support absorption, is the preferred supplemental form. Some practitioners recommend pairing it with vitamin K2, which helps direct calcium toward bone rather than soft tissue, though the evidence for K2 co-supplementation is mixed rather than definitive.
Iron
Iron deficiency is one of the most commonly missed nutritional diagnoses in people running aggressive weight-loss protocols. The symptom picture, fatigue, brain fog, reduced exercise tolerance, and hair shedding, overlaps heavily with what retatrutide already produces at high doses. Many users wait these symptoms out, assuming they are drug effects. Often, they are correctable iron deficiency.
The mechanism is direct. Red meat is among the most concentrated dietary sources of readily absorbed iron. Retatrutide suppresses appetite sharply, and calorie-dense foods like red meat are typically among the first to be reduced. Menstruating women have substantially higher iron requirements than men, and meeting those requirements while eating very little food is genuinely difficult. The result is that ferritin, which measures stored iron rather than what is currently circulating, can fall well below functional ranges while serum iron still appears normal on a basic panel.
Low ferritin means the body cannot deliver oxygen to working muscles efficiently. Training capacity falls. The caloric burn from exercise decreases. And the weight-loss plateau that follows is attributed to the drug when the real problem is a correctable nutritional gap.
The critical rule here is to test before supplementing. Iron is one of the few nutrients where excess causes real harm, including oxidative stress and worsened GI symptoms that retatrutide already produces. Ferritin is the marker, and supplementation is appropriate only when bloodwork confirms a shortfall. The form of iron supplement matters too: ferrous bisglycinate is considerably gentler on a GI system that is already being challenged than ferrous sulfate.
Vitamin B12
B12 is found almost exclusively in animal products. A person eating a restricted, low-variety diet on retatrutide is eating far less of those foods. B12 is also absorbed in the stomach with the help of a protein called intrinsic factor, and anything that alters normal gastric function, including the motility effects of a triple agonist, can reduce the efficiency of that process.
Deficient B12 does not produce dramatic immediate symptoms. It erodes energy steadily, slows nerve signaling, and allows a molecule called homocysteine to accumulate in the blood. Elevated homocysteine is the functional marker that identifies B12 or folate insufficiency even when serum B12 appears borderline-normal on standard testing. Checking both serum B12 and homocysteine together gives a more complete picture than either alone.
Methylcobalamin, the methylated form of B12, is better used by the body than cyanocobalamin, which is the cheaper and more common form found in most standard supplements. Sublingual delivery, meaning a tablet that dissolves under the tongue, bypasses the gastric absorption step entirely, which makes it a practical choice for anyone whose GI function is being actively altered by the drug.
Managing What Makes Retatrutide Hard to Run
The GI side-effect burden on retatrutide is heavier than most people expect, particularly coming from semaglutide or tirzepatide. Nausea during titration is the primary reason people reduce their dose or discontinue. Building the support stack before the nausea arrives is significantly more effective than trying to add it once symptoms are established.
Ginger
Ginger is the most evidence-backed non-pharmaceutical option for nausea management in this context, despite the fact that it has not been tested specifically in retatrutide trials. The mechanism involves compounds called gingerols and shogaols, which interact with receptors in the gut wall that regulate nausea signaling, and ginger also has modest effects on gastric motility through a separate pathway.
Controlled trials in people undergoing chemotherapy and in pregnancy, two contexts involving severe nausea from very different triggers, consistently show ginger producing meaningful reductions in symptom scores. These triggers differ mechanically from retatrutide's delayed gastric emptying, and that is an honest distinction worth making. The research does establish that ginger acts on a nausea pathway broad enough to be relevant across causes, and that it is safe and well-tolerated in realistic amounts.
It will not stop the nausea. On a compound where nausea affects 60 percent of users and is the primary driver of dose reduction, taking the edge off is genuinely useful.
Magnesium
Magnesium does two jobs on retatrutide, which makes it one of the higher-value entries on this list. The first is addressing a genuine deficiency. People running aggressive caloric restriction consistently fall short of magnesium intake targets. GI symptoms, particularly diarrhea during titration, accelerate magnesium loss further. The downstream symptoms, including muscle cramps, disrupted sleep, and fatigue, overlap so heavily with retatrutide side effects that they are routinely mistaken for drug effects and left uncorrected.
The second job is managing constipation. Retatrutide slows gastric motility as part of how it suppresses appetite, and that same slowing produces constipation in a significant proportion of users. Magnesium glycinate, specifically, can ease bowel transit without causing the aggressive laxative effect that makes magnesium oxide difficult to tolerate on an already-sensitive GI system. This is why the form matters: oxide is the most common form in cheap supplements and the worst choice for someone already managing GI symptoms.
Bedtime dosing addresses the nighttime muscle cramps that frequently disrupt sleep and creates natural separation from other oral supplements to reduce absorption competition.
The correct marker here is RBC magnesium, meaning magnesium measured inside red blood cells. Serum magnesium is tightly regulated by the body and stays in a normal range even when tissue stores are significantly depleted. RBC magnesium reflects what is actually available at the cellular level.
Electrolytes
When food intake falls sharply, electrolyte intake falls with it. Sodium comes primarily from food, and a person eating very little is eating very little sodium. Potassium follows the same pattern. On retatrutide, GI symptoms during titration, particularly vomiting and diarrhea, accelerate losses beyond what reduced intake alone would produce.
Electrolyte depletion does not just cause weakness and cramping in isolation. It amplifies nausea. One of the underappreciated dynamics in triple-agonist users is that low electrolytes worsen the same GI symptoms that caused the depletion, creating a feedback loop that worsens progressively without intervention. Breaking that loop early is one of the more practical things this stack accomplishes.
The approach is straightforward: maintain adequate sodium and potassium through food and, where intake is too low to achieve that, through an electrolyte supplement dissolved in water. Anyone also taking an SGLT2 inhibitor alongside retatrutide faces compounded depletion from both agents and warrants closer attention to hydration and electrolyte status than the general protocol would suggest.
Soluble Fiber
Psyllium husk, the most practical and well-studied form of soluble fiber, manages the constipation side of retatrutide's GI profile. It works by absorbing water in the gut to form a gel that keeps stool moving through a digestive system that the drug has slowed considerably.
The timing caveat is critical and not optional: do not introduce a fiber supplement in the first week or two of any new dose level. Early titration is when nausea is worst, and bulk fiber before the GI system has adapted consistently worsens that nausea. Wait until the acute nausea phase has settled, then introduce fiber gradually rather than at a full dose from day one.
A second timing rule applies to oral medications. Retatrutide already slows gastric emptying by 30 to 40 percent. Soluble fiber slows absorption further for everything it contacts. Taking fiber close to oral contraceptives, thyroid hormone, or any other time-sensitive medication compounds the absorption delay in a way that can reduce the effectiveness of those medications. Separate fiber from oral medications by at least two hours.
Probiotics and Digestive Enzymes
The bacterial populations living in the gut respond to dramatic changes in what you eat. Retatrutide users are typically consuming very different foods in very different quantities than before starting the drug, and that dietary shift alters the gut environment in ways that affect digestion and GI comfort. Probiotic supplementation supports the bacterial populations that regulate gut motility and barrier function.
Digestive enzymes, which help break down food components that an altered GI environment may not process as efficiently, are reported by a meaningful number of community users to reduce bloating and discomfort during the adjustment period. The clinical trial evidence for either intervention in the specific context of triple-agonist use is not established. What exists is a plausible mechanism, consistent user-reported experience from the broader GLP-1 community, and no meaningful safety concern. These belong in the stack as supportive additions rather than load-bearing interventions.
Berberine and the Blood-Sugar Amplification Question
Berberine
Berberine is a plant-derived compound that activates an enzyme called AMPK inside cells. AMPK is essentially a cellular fuel gauge that, when activated, tells cells to stop storing energy and start burning it. Metformin, the most widely prescribed diabetes medication, works through a related mechanism, which is why berberine is sometimes described in functional medicine as a natural analog.
Retatrutide already improves blood glucose control and insulin sensitivity through its GLP-1 and GIP receptor activity. Berberine pushes the same metabolic outcome through a complementary cellular route, supporting the glucose and insulin improvements that make retatrutide effective beyond weight loss alone.
The additive effect is also the risk. Combining retatrutide with berberine in a person who is also taking metformin, a sulfonylurea like glipizide, or insulin creates a meaningful risk of blood glucose falling too low. This is not a theoretical concern. It is a documented clinical problem with stacked glucose-lowering agents. Anyone combining berberine with retatrutide needs to be transparent with their clinician about it, and anyone on a diabetes medication needs to discuss the combination before adding berberine. For a retatrutide user who is not on additional glucose-lowering medications, berberine's metabolic benefits are a genuine complement to what the drug is doing. For anyone who is, the risk-benefit calculation changes materially.
Protecting the Lean Mass That Retatrutide Would Otherwise Take
The most important thing to understand about retatrutide's weight loss is that the body does not distinguish between fat and muscle when it is in a deep energy deficit. Clinical data from GLP-1 family trials consistently shows that 25 to 40 percent of weight lost on these agents is lean mass in people who do not take active steps to preserve it. Retatrutide's glucagon arm, by driving hepatic amino acid breakdown for fuel, adds an additional catabolic pressure that the mono-agonists do not impose. The scale of weight loss this compound produces, up to 24 to 30 percent of body weight, means the absolute amount of lean mass at risk is larger than anything in the GLP-1 family to date.
Protein
Protein is the primary intervention and no supplement on this list replaces it. The goal is to provide enough amino acids that the body does not need to break down muscle to supply the liver with the fuel the glucagon receptor is demanding. This is a direct consequence of retatrutide's triple mechanism and not a concern that applies in the same way to semaglutide users.
Leucine is the specific amino acid that triggers the cellular machinery responsible for building and maintaining muscle protein. The pathway it activates, called mTOR, requires a meaningful amount of leucine per meal to switch on rather than a small amount spread thinly throughout the day. Whey protein is particularly useful here because it is fast-digesting, high in leucine, and easy to consume when appetite is suppressed and full meals feel difficult to complete.
For users whose appetite suppression makes it hard to hit protein targets through whole food, leucine-rich protein supplements and essential amino acid formulas fill the gap without requiring a large caloric commitment. On a drug that can suppress appetite so aggressively that even a modest-sized meal feels overwhelming, the ability to get adequate protein in a small volume is a practical advantage.
Creatine Monohydrate
Creatine belongs in this stack for a reason distinct from protein. Protein provides the raw material to build and maintain muscle. Creatine provides the fuel that muscles use during high-intensity training, specifically a phosphate-based energy currency called ATP that powers short, demanding efforts like resistance training.
In a deep caloric deficit, muscles have less stored energy to work with. Training feels harder. You fatigue faster. You lift less. And when you lift less, you give the body a weaker signal to preserve lean mass. Creatine partially compensates by increasing the muscle's stored fuel supply, which allows training quality to remain higher during a significant restriction period than it would otherwise be.
The research supporting creatine for lean mass preservation during caloric restriction is clinical and robust. It is among the most studied supplements in sports science and has a well-established safety profile. There are no documented drug interactions between creatine and retatrutide or any GLP-1 medication.
One bloodwork note: creatine supplementation raises serum creatinine slightly. Creatinine is a breakdown product that the kidneys filter out, and a mild elevation is a benign consequence of creatine use. It can be misread as a sign of kidney impairment if the clinician ordering your labs does not know you are taking creatine. Mention it.
HMB
HMB, which stands for beta-hydroxy beta-methylbutyrate, is a compound the body produces naturally in small amounts when it breaks down the amino acid leucine. In supplement form, it signals muscle tissue to slow protein breakdown. Its job is not to build muscle. Its job is to slow the rate at which muscle is lost during a catabolic period.
The evidence for HMB is less consistent than for creatine. Several trials have shown effects on lean mass preservation during caloric restriction, but results are more variable and effect sizes are smaller. It appears in community protocols for retatrutide specifically because the scale of weight loss this drug produces creates a more extreme catabolic environment than most supplements are tested against. As a third line of defense alongside protein and creatine, it has a reasonable mechanistic rationale. It is not a primary recommendation, but for someone running an aggressive retatrutide protocol at higher doses over an extended period, it earns its place as a supporting intervention.
Cautions and Interactions on Retatrutide
Blood glucose and stacked glucose-lowering agents
This is the most serious interaction on this list. Retatrutide stimulates insulin secretion through its GLP-1 and GIP receptor activity. Combining it with any other agent that lowers blood glucose creates an additive effect that can push glucose dangerously low. The agents of concern include insulin itself, sulfonylureas such as glipizide and glyburide, berberine, and any supplement or medication that lowers blood sugar through any mechanism. This is not a mild interaction that can be managed informally. It requires medical supervision, active glucose monitoring, and typically a dose adjustment of the diabetes medication before retatrutide is added. Do not add berberine to a retatrutide protocol that includes a sulfonylurea or insulin without direct clinician involvement.
Fiber timing and nausea worsening
Introducing a fiber supplement during the first one to two weeks at any new dose level is likely to worsen nausea. Bulk fiber in a gut already operating at reduced speed adds to the backlog. Wait until the acute nausea phase has passed at a given dose, introduce fiber gradually, and keep it separated from oral medications by at least two hours to avoid compounding retatrutide's existing effect on absorption.
Hydration and creatine
Creatine draws water into muscle cells, which is part of why it works. On a drug that already reduces fluid intake through appetite suppression and that can cause significant fluid losses through GI symptoms, maintaining adequate hydration while taking creatine requires deliberate attention. This is not a dangerous combination, but thirst is often suppressed along with appetite on retatrutide. Relying on thirst to guide hydration is not sufficient. Drink water on a schedule rather than waiting for the signal.
Oral contraceptive absorption
Retatrutide's reduction in gastric emptying rate slows the absorption of all oral medications. Oral contraceptives are a particular concern because their efficacy depends on consistent, predictable absorption. Users relying on oral contraceptives for pregnancy prevention should discuss switching to a non-oral method, such as a patch, injection, or IUD, particularly during dose escalation when gastric slowing is most pronounced and most variable.
Timed oral medications
Thyroid hormone replacement, many cardiac medications, and some mood-stabilizing medications have absorption windows that are sensitive to changes in gastric motility. Anyone on levothyroxine should expect to need more frequent thyroid function testing during dose escalation, because the amount of hormone absorbed per dose may shift as gastric motility changes with each new dose level. The same principle applies to other narrow-therapeutic-index drugs, and it is worth flagging retatrutide explicitly when discussing any timed oral medication with a prescriber.
Warfarin and high-dose omega-3 fatty acids
High-dose omega-3 fatty acids, at amounts above roughly three grams per day of EPA and DHA combined, have mild blood-thinning properties. In combination with warfarin, this can make INR values less predictable. Anyone on warfarin should inform their clinician before adding a high-dose omega-3 supplement and should expect more frequent INR monitoring while also titrating retatrutide.
Frequently Asked Questions
How much of each supplement should I take with retatrutide?
The right amount depends on where you are in your protocol, what your bloodwork shows, how much you are getting from food, and what other medications you are taking. A dose appropriate for someone at week six of a stable maintenance phase may be wrong for someone still working through the early titration steps. MyPeptidePal takes those variables into account and builds a personalized plan around your specific situation rather than applying a generic number.
Which blood markers should I monitor while on retatrutide?
The markers that matter most for supplement decisions are ferritin for iron status, 25-hydroxyvitamin D for vitamin D stores, RBC magnesium for actual tissue magnesium levels, and serum B12 alongside homocysteine for B12 and methylation status. A basic metabolic panel covering electrolytes is worth running regularly given the fluid and food intake changes the drug produces. Because retatrutide actively manages blood glucose, HbA1c is relevant at baseline and at regular intervals to track how your glucose metabolism is responding. Body composition testing, ideally a DEXA scan rather than a scale weight, gives the most useful picture of whether the lean mass preservation stack is working.
Do any of these supplements interfere with how retatrutide works?
Most supplements on this list have no pharmacological interaction with retatrutide itself. The important exception is berberine: combining a potent glucose-lowering supplement with a drug that stimulates insulin secretion creates an additive effect that can push blood sugar too low, particularly in people also taking metformin, sulfonylureas, or insulin. High-dose soluble fiber taken close to other oral medications may slow their absorption further on top of retatrutide's existing gastric-emptying delay, which is a timing issue rather than a pharmacological interaction and is managed by separating fiber from other medications by at least two hours.
Can I start all of these at once, or should I introduce them gradually?
GI side effects are most intense during the first week or two at each new dose level, and introducing multiple new supplements during that window makes it harder to identify what is causing any new symptoms. A practical sequence is to start protein and creatine at the same time as the drug, or before it, since those are the interventions with the most immediate relevance to lean mass. Add the deficiency-correction supplements once you have a baseline bloodwork panel to confirm what actually needs correcting. Bring in fiber last, after the initial nausea at each dose level has settled, and introduce it gradually.
Do I need to keep taking these after I stop retatrutide?
Some of them, yes. Deficiencies in vitamin D, iron, and B12 do not automatically resolve when you stop the drug. If levels were genuinely depleted during the protocol, they need time and continued supplementation to recover. The lean-mass preservation argument, specifically protein and creatine, is arguably more important in the period immediately after stopping, because the appetite suppression disappears but any muscle lost during the protocol does not automatically restore. The case for high protein intake and resistance training does not expire when the injection stops.
Ready to turn this stack into numbers?
This content is for informational and educational purposes only. It does not constitute medical advice, diagnosis, or treatment recommendations. MyPeptidePal is not a medical provider. Always consult a qualified healthcare professional before starting, modifying, or stopping any health protocol, supplement regimen, or therapeutic intervention.
Sources
The information in this guide is drawn from the MyPeptidePal knowledge base, which brings together published research, clinical data, and documented real-world use of Retatrutide and the nutrients that support it in one place.
About MyPeptidePal
About the Author
Marcus Reid is a functional medicine researcher, data analyst, and peptide specialist, and one of the people who built MyPeptidePal. The platform exists in part because of the years he spent immersed in clinical literature, real-world protocols, and the kind of hands-on experimentation that most textbooks skip entirely. He is not a physician and does not pretend to be. What he is, is someone who has done the work to understand how these compounds actually function at a biological level, what the research actually says versus what the forums claim, and how to explain it in a way that makes sense to anyone willing to learn. At MPP, Marcus contributed to building the knowledge base, the protocol frameworks, and the research systems that power the platform. His work covers tissue repair, metabolic health, hormonal optimization, longevity, cognitive function, and cosmetic applications. When the science gets complicated, his job is to make it click.


